ID   HyCyte T24 hADAR_p.E912A_c.2735A>C
AC   CVCL_E2Q9
SY   hADAR_p.E912A_c.2735A>C T24
DR   Hysigen; CGMU-M2163
CC   Population: Caucasian; Swedish.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2163).
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple_edited; p.Glu912Ala (c.2735A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2163).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//